New 'Living Drug' trial aims to fight advanced cancers that resist other treatments

NCT ID NCT06060613

Summary

This study is testing a new type of personalized cell therapy called OBX-115 in adults with advanced melanoma or non-small cell lung cancer that has progressed after standard treatments. Doctors take a patient's own immune cells from a tumor, genetically engineer them to be more powerful, and infuse them back to fight the cancer. The main goals are to see if the treatment is safe and if it can shrink tumors.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC MELANOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Allegheny Research Institute (Melanoma/NSCLC)

    RECRUITING

    Pittsburgh, Pennsylvania, 15224, United States

    Contact Email: •••••@•••••

    Contact

  • James Graham Brown Cancer Center (Melanoma/NSCLC)

    RECRUITING

    Louisville, Kentucky, 40202, United States

    Contact

    Contact Email: •••••@•••••

  • M.D. Anderson Cancer Center (Melanoma/NSCLC)

    RECRUITING

    Houston, Texas, 77030, United States

    Contact

    Contact Email: •••••@•••••

  • Memorial Sloan Kettering (Melanoma/NSCLC)

    RECRUITING

    New York, New York, 10065, United States

    Contact

    Contact Phone: •••-•••-••••

    Contact Phone: •••-•••-••••

  • Orlando Health Cancer Institute (Melanoma/NSCLC)

    RECRUITING

    Orlando, Florida, 32806, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Stanford Cancer Institute (Melanoma/NSCLC)

    RECRUITING

    Stanford, California, 94305, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The Angeles Clinic and Research Institute (Melanoma)

    RECRUITING

    Los Angeles, California, 90025, United States

    Contact

    Contact Email: •••••@•••••

  • The Ohio State University

    RECRUITING

    Columbus, Ohio, 43210, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • USC Norris Comprehensive Cancer Center (Melanoma/NSCLC)

    RECRUITING

    Los Angeles, California, 90033, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.